Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Benzydamine hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Benzydamine 0.15% oromucosal spray sugar free
1203010E0AAABAB
|
Benzydamine hydrochloride (Mouthwash) | Benzydamine hydrochloride | Ear, Nose and Oropharynx | 87,695 |
|
Benzydamine 0.15% mouthwash sugar free
1203010E0AAAAAA
|
Benzydamine hydrochloride (Mouthwash) | Benzydamine hydrochloride | Ear, Nose and Oropharynx | 39,934 |
|
Difflam 0.15% spray
1203010E0BBABAB
|
Difflam (Mouthwash) | Benzydamine hydrochloride | Ear, Nose and Oropharynx | 23,868 |
|
Difflam Oral Rinse 0.15% solution
1203010E0BBAAAA
|
Difflam (Mouthwash) | Benzydamine hydrochloride | Ear, Nose and Oropharynx | 15,269 |
|
Difflam 0.15% Sore Throat Rinse
1203010E0BBACAA
|
Difflam (Mouthwash) | Benzydamine hydrochloride | Ear, Nose and Oropharynx | 779 |
|
Benzydamine 0.30% oromucosal spray sugar free
1203010E0AAACAC
|
Benzydamine hydrochloride (Mouthwash) | Benzydamine hydrochloride | Ear, Nose and Oropharynx | 461 |
|
Benzydamine 3mg lozenges sugar free
1203030Y0AAAAAA
|
Benzydamine hydrochloride (Lozenge) | Benzydamine hydrochloride | Ear, Nose and Oropharynx | 284 |
|
Benzydamine 3% cream
1003020F0AAAAAA
|
Benzydamine hydrochloride (Topical) | Benzydamine hydrochloride | Musculoskeletal and Joint Diseases | 130 |
|
Difflam 3% cream
1003020F0BBAAAA
|
Difflam (Topical) | Benzydamine hydrochloride | Musculoskeletal and Joint Diseases | 101 |
|
Difflam 3mg lozenges orange-honey
1203030Y0BCADAA
|
Difflam | Benzydamine hydrochloride | Ear, Nose and Oropharynx | 55 |
|
Difflam 3mg lozenges lemon
1203030Y0BCABAA
|
Difflam | Benzydamine hydrochloride | Ear, Nose and Oropharynx | 36 |
|
Difflam 3mg lozenges mint
1203030Y0BCACAA
|
Difflam | Benzydamine hydrochloride | Ear, Nose and Oropharynx | 23 |
|
Difflam 3mg lozenges eucalyptus
1203030Y0BCAAAA
|
Difflam | Benzydamine hydrochloride | Ear, Nose and Oropharynx | 15 |
|
Difflam-P 3% cream
1003020F0BBABAA
|
Difflam (Topical) | Benzydamine hydrochloride | Musculoskeletal and Joint Diseases | No data available |
|
Lozamine 3mg lozenges
1203030Y0BBAAAA
|
Lozamine | Benzydamine hydrochloride | Ear, Nose and Oropharynx | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.